Clinical Trials Browser

Nausea × Head & Neck × Clear all

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Phase 2 Terminated

6 enrolled 5 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

NCT00040911 2013-05-31

Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma

Phase NA Completed

17 enrolled

CNSGenitourinaryGynecologicHead & NeckLymphoidSarcoma

Ovarian Germ Cell Cancer, Brain Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Lymphoma, Nausea, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Vomiting, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Phase 4 Completed

452 enrolled

Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Clinical Trials

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma

Subcutaneous Amifostine Safety Study